Rinaldo Poncio Mendes

• Abstract

  Paracoccidioidomycosis (PCM) is systemic mycosis caused by the thermal dimorphic fungus of genus Paracoccidioides, leading to either acute/subacute (AF) or chronic (CF) clinical forms. Numerous CF patients after treatment exhibit sequels, such as pulmonary and adrenal fibrosis. Monocytes are cells that are involved in the inflammatory response during active infection as well as in the fib…

  Alterações fenotípicas e funcionais de monócitos sanguineos periféricos de pacientes com a forma crônica da paracoccidioidomicose, antes e após tratamento., PUB.ART

• Abstract

  A review of 400 clinical records of paracoccidioidomycosis (PCM) patients, 93 with the acute/subacute (AF) and 307 with the chronic form (CF), attended from 1977 to 2011, selected as to the schedule of release for study by the Office of Medical Records at the University Hospital of the Faculdade de Medicina de Botucatu - São Paulo State University - UNESP, was performed to detect cases in…

  Prevalence and serological diagnosis of relapse in paracoccidioidomycosis patients., PUB.ART
• Influência do tratamento antifúngico no perfil de monócitos, macrófagos e células dendríticas em pacientes com paracoccidioidomicose e na infecção murina, AP.R

(Only some records are available in English at this moment)

• Abstract

  The paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by the fungus Paracoccidioides brasiliensis. It is the most common systemic mycosis in South America, especially in the Southern and Southeastern regions of Brazil. The clinical form of PCM varies from a self-limited infection to a severe, progressive, and sometimes fatal disease, which involves pulmonary and extr…

  Evaluation of adrenal impairment in patients with paracoccidioidomycosis, BP.IC
• Accuracy of the enzyme linked immunosorbent assay and its contribution in the follow-up of paracoccidioidomycosis-patients under treatment and diagnosis of relapse, BP.MS